HCN2 channels: a potential therapeutic target for orofacial neuropathic pain after trigeminal nerve injury

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels have recently emerged as promising targets for the treatment of neuropathic pain. This study investigated the potential involvement of HCN2 channels in the development of trigeminal neuropathic pain following peripheral nerve injury. Infraorbital nerve chronic constriction injury (ION-CCI) model was adopted to rats, and head withdrawal thresholds (HWT) to mechanical stimulation were assessed pre- and postoperatively, as well as after pharmacological intervention. In the trigeminal ganglion (TG), intracellular cyclic adenosine monophosphate (cAMP) and cytoplasmic protein kinase A (PKA) levels were quantified by Enzyme-Linked Immunosorbent Assay (ELISA), while Hcn2 mRNA expression was evaluated by quantitative Polymerase Chain Reaction (qPCR). Immunohistochemical analysis was performed to assess phosphorylated cAMP response element-binding protein (pCREB) expression in the TG and HCN2 expression in infraorbital nerve (ION) axons. In the TG, cAMP and pCREB levels were elevated, whereas cytoplasmic PKA and Hcn2 mRNA levels were reduced. Axonal HCN2 expression was increased in CCI rats. On day 14, HWT was significantly reduced following CCI but was ameliorated by local administration of the HCN channel blocker ivabradine at the site of axonal injury. Collectively, these findings suggest that CCI-induced alterations in cAMP-PKA-pCREB signaling promote HCN2 accumulation in injured axons, thereby contributing to the development of orofacial neuropathic pain following peripheral nerve injury.

Hyperpolarization-activated cyclic nucleotide-gated channel; Rat; Neuropathic pain; Orofacial; Trigeminal

[1] Sharma S, Rana P, Dhingra N, Kaur T. Insights into ion channels to identify drug target for neuropathic pain management. Inflammopharmacology. 2025; 33: 4455–4475.

[2] Ohashi N, Ohashi M, Hoshino R, Deguchi H, Baba H. Ivabradine reduces neuropathic pain after spinal cord injury by inhibiting excitatory synaptic transmission in the spinal dorsal horn. Neuroscience Letters. 2025; 848: 138113.

[3] Ohashi N, Uta D, Ohashi M, Baba H. Analgesic effect of ivabradine against inflammatory pain mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels expressed on primary afferent terminals in the spinal dorsal horn. Pain. 2022; 163: 1356–1369.

[4] Song Y, Gao L. Spinal nerve axotomy: effects on Ih in vivo and HCNs in DRG neurons. International Journal of Molecular Sciences. 2024; 25: 12889.

[5] Qingguang Q, Zujiang C, Weimin F, Junhua LI, Liqing L, Yikai LI. Hyperpolarization-activated cyclic nucleotide-gated 2 contributes to electroacupuncture analgesia on lumbar disc herniation-induced radicular pain through activation of microglia in spinal dorsal horn. Journal of Traditional Chinese Medicine. 2022; 42: 372–378.

[6] Lei X, Zeng J, Yan Y, Liu X. Blockage of HCN channels inhibits the function of P2X receptors in rat dorsal root ganglion neurons. Neurochemical Research. 2022; 47: 1083–1096.

[7] Toraman A, Toraman E, Özkaraca M, Budak H. Increased nociceptive sensitivity is associated with periodontal inflammation and expression of chronic pain genes in gingival tissues of male rats. Chemico-Biological Interactions. 2022; 366: 110128.

[8] Ding W, You Z, Shen S, Yang J, Lim G, Doheny JT, et al. An improved rodent model of trigeminal neuropathic pain by unilateral chronic constriction injury of distal infraorbital nerve. The Journal of Pain. 2017; 18: 899–907.

[9] Li Z, Cui D, Qiu C, Song X. Cyclic nucleotide signaling in sensory neuron hyperexcitability and chronic pain after nerve injury. Neurobiology of Pain. 2019; 6: 100028.

[10] Ma Y, Chen J, Chen C, Wei B, Liu X. Suppression of HCN channels in the spinal dorsal horn restores KCC2 expression and attenuates diabetic neuropathic pain. Neuroscience Letters. 2024; 822: 137626.

[11] Korczeniewska OA, Husain S, Hoque M, Soteropoulos P, Khan J, Eliav E, et al. Time-course progression of whole transcriptome expression changes of trigeminal ganglia compared to dorsal root ganglia in rats exposed to nerve injury. The Journal of Pain. 2024; 25: 101–117.

[12] Jiang Y, Xing G, Wang S, Tu H, Chi Y, Li J, et al. Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat. Pain. 2008; 137: 495–506.

[13] Howard P. HCN channels: novel therapeutic targets for peripheral neuropathic pain. BMJ Supportive & Palliative Care. 2025; 15: 469–472.

[14] Young GT, Emery EC, Mooney ER, Tsantoulas C, McNaughton PA. Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels. Pain. 2014; 155: 1708–1719.

[15] Schmid AB, Fundaun J, Tampin B. Entrapment neuropathies: a contemporary approach to pathophysiology, clinical assessment, and management. Pain Reports. 2020; 5: e829.

[16] Tanaka S, Ishida T, Ishida K, Fuseya S, Ito M, Sakamoto A, et al. A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers. Scientific Reports. 2022; 12: 17246.

[17] Korczeniewska OA, Husain S, Khan J, Eliav E, Soteropoulos P, Benoliel R. Differential gene expression in trigeminal ganglia of male and female rats following chronic constriction of the infraorbital nerve. European Journal of Pain. 2018; 22: 875–888.

[18] Korczeniewska OA, Katzmann Rider G, Gajra S, Narra V, Ramavajla V, Chang Y, et al. Differential gene expression changes in the dorsal root versus trigeminal ganglia following peripheral nerve injury in rats. European Journal of Pain. 2020; 24: 967–982.